Plinest Polynucleotide Treatment in London

Results from a full course of plinest polynucleotide treatment typically persist for six to nine months, with some patients noticing benefits extending to twelve months depending on age, skin condition, and lifestyle. Because it is used with the aim of supporting the skin’s regenerative response, longevity varies according to how well individual tissue responds and how consistently post-treatment skincare is maintained. Maintenance sessions every six to twelve months are commonly recommended to sustain the improvements in skin quality, hydration, and overall skin health achieved through the initial course.

Plinest is a CE-marked injectable medical device derived from highly purified salmon DNA, selected for its compatibility profile with human tissue. Because it does not add volume and carries no live cellular material, it differs from filler-based or stem cell procedures in both mechanism and treatment intent. As with any injectable treatment, individual medical history, skin condition, and clinical suitability must be carefully evaluated beforehand. Patients with known fish allergies, certain autoimmune conditions, or active skin infections may not be suitable candidates.

The appropriate number of sessions depends on the individual skin condition, the severity of concerns, and the goals established during consultation. Most patients begin with a course of two to three plinest polynucleotide treatments, spaced two to four weeks apart, to allow cumulative regenerative activity to develop progressively. A single session may suit milder concerns or patients already in a maintenance phase. A personalised plan confirming session number, frequency, and spacing is provided following clinical assessment.

Discomfort during plinest treatment is generally mild and well-tolerated. A topical anaesthetic is applied to the area in advance to reduce sensation during the injections. Patients may notice a brief stinging or pressure at individual injection sites, but this resolves promptly once each injection is complete. Most individuals describe the experience as manageable, and the practitioner can adjust technique where necessary to support comfort. Any residual tenderness following the session typically resolves within one to two days.

Plinest polynucleotide treatment is associated with minimal downtime. Small raised bumps at injection sites are common but typically subside within a few hours. Some patients experience mild redness, swelling, or bruising in the treatment area for 24 to 72 hours, reflecting normal tissue activity in the early phase of regeneration. Makeup should generally be avoided for 24 hours post-treatment, and sun exposure should be minimised in the days that follow. Most patients are able to resume their normal daily activities shortly after their appointment.

Plinest polynucleotide treatment may be appropriate for adults experiencing fine lines and wrinkles, loss of skin elasticity, dull skin, uneven texture, dark circles, or post-inflammatory acne scarring. It may be suitable for a wide range of skin types and can be applied to the face, periorbital region, neck, and scalp. It is not recommended for individuals who are pregnant or breastfeeding, those with a known fish allergy, or patients presenting with active skin infections or certain autoimmune conditions. Suitability is determined by a thorough clinical assessment during your initial consultation.

Initial improvements in hydration and skin radiance may be noticeable within the first two to three weeks following the first treatment. Deeper changes in texture and firmness — including improvements in skin texture, firmness, and visible reduction in fine lines — typically develop over four to eight weeks as tissue response develops and remodelling continues over time. The full results from a complete course are generally most apparent approximately eight to twelve weeks after the final session, with continued improvements in overall skin quality observable throughout this period.

Plinest polynucleotide treatment is frequently combined with microneedling, which enhances transdermal delivery and may further support collagen-related tissue response through a dual-action approach. It can also be integrated into broader aesthetic plans alongside anti-wrinkle treatments or other regenerative protocols, depending on clinical suitability. However, certain combinations — including IPL or intense light treatments — are generally avoided due to increased risk of post-procedure swelling. Timing and sequencing of any combined treatments are planned carefully during consultation to reflect individual skin needs and goals.